ARK Investment Management’s Beam Therapeutics BEAM Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$289M	Sell	12,133,433 -333,756	-3%	-$9.26M	2.25%	14
2025 Q4	$346M	Buy	12,467,189 +1,428,355	+13%	+$36.4M	2.29%	12
2025 Q3	$268M	Buy	11,038,834 +2,190,993	+25%	+$43.6M	1.59%	16
2025 Q2	$151M	Buy	8,847,841 +367,752	+4%	+$6.4M	1.1%	27
2025 Q1	$166M	Buy	8,480,089 +1,412,060	+20%	+$37M	1.66%	19
2024 Q4	$175M	Buy	7,068,029 +536,930	+8%	+$13.7M	1.46%	20
2024 Q3	$160M	Sell	6,531,099 -1,095,040	-14%	-$28.3M	1.46%	21
2024 Q2	$179M	Sell	7,626,139 -556,035	-7%	-$13.7M	1.59%	22
2024 Q1	$270M	Sell	8,182,174 -1,211,715	-13%	-$37.8M	1.87%	15
2023 Q4	$256M	Buy	9,393,889 +609,998	+7%	+$15.2M	1.51%	21
2023 Q3	$211M	Buy	8,783,891 +401,296	+5%	+$10.8M	1.62%	20
2023 Q2	$268M	Sell	8,382,595 -190,834	-2%	-$6.19M	1.77%	19
2023 Q1	$263M	Buy	8,573,429 +360,298	+4%	+$14.2M	1.8%	19
2022 Q4	$321M	Sell	8,213,131 -277,805	-3%	-$12.4M	2.78%	12
2022 Q3	$405M	Sell	8,490,936 -301,128	-3%	-$17.2M	2.82%	12
2022 Q2	$309M	Buy	8,792,064 +591,315	+7%	+$23.5M	1.84%	16
2022 Q1	$470M	Buy	8,200,749 +217,348	+3%	+$14.3M	1.96%	15
2021 Q4	$636M	Buy	7,983,401 +1,141,679	+17%	+$97.8M	1.92%	17
2021 Q3	$595M	Buy	6,841,722 +380,355	+6%	+$38.2M	1.43%	21
2021 Q2	$832M	Buy	6,461,367 +1,682,263	+35%	+$134M	1.55%	17
2021 Q1	$383M	Buy	4,779,104 +3,647,481	+322%	+$347M	0.76%	40
2020 Q4	$92.4M	Buy	+1,131,623	New	+$55.6M	0.25%	74